Kshirsagar O - Search Results

1

Who Is at Risk for New Hepatitis B Infections Among People With HIV?

Sladic JM, Taylor BS, Thamer M, Vigil KJ, Kshirsagar O, Taranova A, McCracken A, Sanchez CG, Jain MK. Sladic JM, et al. Among authors: kshirsagar o. Open Forum Infect Dis. 2023 Jul 17;10(8):ofad375. doi: 10.1093/ofid/ofad375. eCollection 2023 Aug. Open Forum Infect Dis. 2023. PMID: 37539064 Free PMC article.

2

Persistent low prevalence of hepatitis B vaccination among people with HIV: Time for a change?

Garcia A, Vigil KJ, Taylor B, Kshirsagar O, Thamer M, Jain MK. Garcia A, et al. Among authors: kshirsagar o. J Viral Hepat. 2023 Oct;30(10):790-792. doi: 10.1111/jvh.13868. Epub 2023 Jul 4. J Viral Hepat. 2023. PMID: 37401399

3

Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment.

Wong RJ, Jain MK, Therapondos G, Shiffman ML, Kshirsagar O, Clark C, Thamer M. Wong RJ, et al. Among authors: kshirsagar o. J Clin Exp Hepatol. 2020 Mar-Apr;10(2):114-123. doi: 10.1016/j.jceh.2019.09.001. Epub 2019 Sep 20. J Clin Exp Hepatol. 2020. PMID: 32189926 Free PMC article.

4

Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.

Wong RJ, Jain MK, Therapondos G, Niu B, Kshirsagar O, Thamer M. Wong RJ, et al. Among authors: kshirsagar o. Am J Gastroenterol. 2021 Jul 1;116(7):1465-1475. doi: 10.14309/ajg.0000000000001195. Am J Gastroenterol. 2021. PMID: 33661148

5

Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems.

Wong RJ, Jain MK, Therapondos G, Niu B, Kshirsagar O, Thamer M. Wong RJ, et al. Among authors: kshirsagar o. J Clin Gastroenterol. 2022 Apr 1;56(4):360-368. doi: 10.1097/MCG.0000000000001530. J Clin Gastroenterol. 2022. PMID: 33780210

6

Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment.

Wong RJ, Jain MK, Therapondos G, Shiffman ML, Kshirsagar O, Clark C, Thamer M. Wong RJ, et al. Among authors: kshirsagar o. Am J Gastroenterol. 2018 Sep;113(9):1329-1338. doi: 10.1038/s41395-018-0033-8. Epub 2018 Mar 9. Am J Gastroenterol. 2018. PMID: 29523864

7

Has Access to Hepatitis C Virus Therapy Changed for Patients With Mental Health or Substance Use Disorders in the Direct-Acting-Antiviral Period?

Jain MK, Thamer M, Therapondos G, Shiffman ML, Kshirsagar O, Clark C, Wong RJ. Jain MK, et al. Among authors: kshirsagar o. Hepatology. 2019 Jan;69(1):51-63. doi: 10.1002/hep.30171. Epub 2018 Dec 18. Hepatology. 2019. PMID: 30019478

8

Impact of the End Stage Renal Disease Prospective Payment System on the Use of Peritoneal Dialysis.

Zhang Q, Thamer M, Kshirsagar O, Zhang Y. Zhang Q, et al. Among authors: kshirsagar o. Kidney Int Rep. 2016 Dec 20;2(3):350-358. doi: 10.1016/j.ekir.2016.12.004. eCollection 2017 May. Kidney Int Rep. 2016. PMID: 29142964 Free PMC article.

9

Organizational status of dialysis facilities and patient outcome: does higher injectable medication use mediate increased mortality?

Zhang Y, Thamer M, Kshirsagar O, Cotter DJ. Zhang Y, et al. Among authors: kshirsagar o. Health Serv Res. 2013 Jun;48(3):949-71. doi: 10.1111/1475-6773.12019. Epub 2012 Dec 6. Health Serv Res. 2013. PMID: 23216415 Free PMC article.

10

Major declines in epoetin dosing after prospective payment system based on dialysis facility organizational status.

Thamer M, Zhang Y, Kaufman J, Kshirsagar O, Cotter D, Hernán MA. Thamer M, et al. Among authors: kshirsagar o. Am J Nephrol. 2014;40(6):554-60. doi: 10.1159/000370334. Epub 2015 Jan 10. Am J Nephrol. 2014. PMID: 25592645 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters